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Gut microbiota alterations associated with reduced
bone mineral density in older adults
Mrinmoy Das 1,2, Owen Cronin3,4, David M. Keohane3, Edel M. Cormac1,2,
Helena Nugent3, Michelle Nugent3, Catherine Molloy3, Paul W. O’Toole1,2,
Fergus Shanahan1,3, Michael G. Molloy3 and Ian B. Jeffery1,2
Abstract
Objective. To investigate compositional differences in the gut microbiota associated with bone homeostasis and
fractures in a cohort of older adults.
Methods. Faecal microbiota profiles were determined from 181 individuals with osteopenia (n = 61) or osteoporosis
(n = 60), and an age- and gender-matched group with normal BMD (n = 60). Analysis of the 16S (V3-V4 region) amplicon
dataset classified to the genus level was used to identify significantly differentially abundant taxa. Adjustments were
made for potential confounding variables identified from the literature using several statistical models.
Results. We identified six genera that were significantly altered in abundance in the osteoporosis or osteopenic groups
compared with age- and gender-matched controls. A detailed study of microbiota associations with meta-data variables
that included BMI, health status, diet and medication revealed that these meta-data explained 1517% of the variance
within the microbiota dataset. BMD measurements were significantly associated with alterations in the microbiota. After
controlling for known biological confounders, five of the six taxa remained significant. Overall microbiota alpha diversity
did not correlate to BMD in this study.
Conclusion. Reduced BMD in osteopenia and osteoporosis is associated with an altered microbiota. These alterations
may be useful as biomarkers or therapeutic targets in individuals at high risk of reductions in BMD. These observations
will lead to a better understanding of the relationship between the microbiota and bone homeostasis.
Key words: osteoporosis, gut microbiota, bone mineral density, elderly, osteopenia.
Rheumatology key messages
. Reduced BMD is associated with taxon-specific signatures in the gut microbiota.
. Medication, anthropometric measures, nutrition and gender are associated with gut microbiota composition.
. Confounders do not explain the microbiotabone density interactions observed here.
Introduction
Osteoporosis, characterized by reduced BMD and degrad-
ation of the micro-architectural structure of bone, affects
over 27.5 million people in Europe [1]. Over the age of 50
years, one in three women and one in five men, worldwide,
will experience an osteoporotic fracture in their lifetime,
representing a significant burden for patients and health
care providers [2]. The aetiology of osteoporosis and its
precursor, osteopenia, is multi-factorial. Contributing fac-
tors include oestrogen and vitamin D deficiency, and gen-
etic modification in regulatory genes such as vitamin D
receptors and TGF-b [3]. Osteoporosis occurrence is
accelerated in patients with immune-mediated inflamma-
tory conditions, where excessive production of pro-inflam-
matory cytokines leads to increased osteoclastic bone
resorption (e.g. IBD, RA and AS) [46]. The gut microbiome
is known to modulate immune cell activities and alterations
in the microbiome have previously been associated with
these inflammatory conditions [7].
The gut microbiome shares a complex relationship with
the host. Development and maturation of the innate and
adaptive immunity in the host is dependent on appropriate
exposure to the gut microbiota [8]. Alterations in the
microbiota may result in immune system modulation or
activation. Circulating osteoclastogenic cytokines may
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be increased in a T-cell-dependent mechanism by the
microbiota, which can drive bone resorption in inflamma-
tory conditions [9]. Several investigations have identified
microbes that regulate the production of hormones or im-
prove uptake of vitamins that are integral to bone health
[10, 11].
Studies with germ-free and antibiotic-treated animals
have indicated the possibility of gut microbial influence
on both bone mass accumulation and turnover. These
animals have shown a reduction in osteoclastic precursor
cell number [12], an increase in bone mass [13], and im-
provement in bone strength and material properties [14].
We have previously identified significant microbiota al-
terations associated with inflamm-aging and frailty in an
elderly cohort [15]. Other studies have demonstrated that
the absence of gut microbiota leads to a reduction in bone
mechanical strength [16] and inversely, long term colo-
nization of pathogen-free gut microbiota increases bone
formation [17]. In contrast, another recent study sug-
gested that microbiota restoration in germ-free mice
does not affect bone loss [18]. These conflicting findings
may, in part, be due to different animal genotypes, the
anti-microbials administered and the absence or presence
of particular taxa in their baseline microbiota.
Our aim in the present study was to determine whether
gut microbiota features are associated with BMD in a
cohort of individuals at high risk of reduced BMD and
fractures. In addition to this, any genus-level taxa asso-
ciated with altered BMD would be identified by comparing
the gut microbiota composition of osteopenic and osteo-
porotic patients with those of age- and gender-matched
controls with normal BMD. Our hypothesis was that intes-
tinal microbiota composition was different in the osteo-
porotic subjects. Furthermore, we developed and
applied a rigorous statistical regime to remove the effect
of potentially confounding variables.
Methods
Subject recruitments and clinical information
Ethical approval was granted by the Clinical Research
Ethics Committee of the Cork Teaching Hospitals before
recruitment. Adult female and male subjects, aged
5575 years, were recruited from the bone densitometry
unit at Cork University Hospital, Cork, Ireland. The indica-
tions for referral for BMD assessment by dual-energy
X-ray absorptiometry were varied, with referrals from pri-
mary, secondary and tertiary care. No single specific re-
ferral criterion was used, and request for assessment was
at the discretion of the attending clinician and not the
study investigators. Written informed consent was ob-
tained from the participants. Individuals with a known his-
tory of alcohol abuse, participation in an investigational
drug trial in the 30 days before enrolment, use of antibi-
otics in the 3 months prior to bone density measurement,
and previous partial or total colectomy were excluded. No
measure was taken to exclude participants with co-exist-
ing OA, aortic calcification or fractures. Altogether, stool
samples were collected from 193 participants. Due to lack
of vitamin D information from 12 samples, they were
excluded from the analysis, resulting in the final dataset
comprising of 181 participants.
Patients underwent dual-energy X-ray absorptiometry
assessment of BMD (g/cm2) at the femoral neck and
antero-posterior lumbar spine (L1-L4) with a GE
Healthcare Lunar iDXA machine (GE Healthcare,
Madison, WI) and enCORE software (V.13.4, 2010) using
standardized methodology [19]. T-score threshold was
used to define three groups based on their BMD. These
were normal BMD (n = 60) with a T-score of 51, patients
with osteopenia (n = 61) with a T-score between 1 and
2.5, and patients with osteoporosis (n = 60) were defined
as having a T-score of 42.5 [20, 21]. The detailed pro-
cedure of recording anthropometric, clinical, dietary and
medications information is recorded in the supplementary
material, available at Rheumatology online.
Molecular methods and bioinformatics
Genomic DNA was extracted from 0.25 g of each of the
faecal samples based on a modified Yu and Morrison
protocol [22]. The V3-V4 region of the 16S rRNA gene
was amplified and sequenced [23] on the Illumina MiSeq
platform at Moorepark Teagasc Food Research Centre,
Fermoy, Ireland. The reads were merged using FLASH
(v1.2.8) [24]. The forward adapters were removed using
cutadapt (v1.8.3). The quality filtering of reads and re-
moval of reverse primers were carried out using the
QIIME (v1.9.1) [25] pipeline with default settings. The re-
moval of chimeric sequences and generation of oper-
ational taxonomic units at 97% identity threshold was
done using USEARCH (v8.1) [26]. Representative oper-
ational taxonomic units were classified using the
Ribosomal Database Project (RDP) database (v11.4) [27]
implemented in mothur (v1.34.4) [28]. a- and b-diversity
measures were produced from a rarefied dataset (10 613
reads per sample).
Statistical analysis
All statistical analyses were carried out in the R statistical
software (v3.4.0) [29]. Significance was determined by a
cut-off P-value 40.05 and P-adjusted 40.05 (Benjamini-
Hochberg procedure) unless stated otherwise. P-adjusted
for pairwise comparison is based on the P-values ob-
tained from all the pairwise comparisons for each variable.
Analysis of meta-data
KruskalWallis, Dunn’s test (v1.3.4) [30] and/or 2 tests
were carried out to identify anthropometric, clinical, diet-
ary and medications significantly different between the
groups. For 2 testing, at least seven participants were
present across the whole dataset for that factor.
Analysis of microbiota data
KruskalWallis test was used to determine significant
difference in a-diversity measures between the groups.
Co-inertia analysis was used to explore the covariance be-
tween the dietary dataset and microbiota dataset. DESeq2
(v1.16.1) [31] was used to identify differentially abundant
2 https://academic.oup.com/rheumatology
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taxa from the microbiota dataset. The dataset was filtered
to retain only those taxa that were present in at least 20%
of the samples across the whole dataset. A DESeq2 model
adjusted for BMI and gender was used to identify genera
that were significantly differentially abundant.
Identification of meta-data variables associated with
beta-diversity
Meta-data variables significantly associated with vari-
ations in global microbiota profiles were identified using
permutational multivariate analysis of variance. A nominal
P-value of 40.05 was used as the analysis was a con-
firmation of previously established associations. Subjects
with diseases such as coeliac disease, diverticulitis and
inflammatory arthritis conditions were present within the
dataset and were tested separately. Inflammatory and
non-inflammatory diseases can alter the microbiota with
a common dysbiosis signature [32]. To investigate the
common signature of microbiota-associated inflammatory
diseases, we created an inflammatory disease index,
where the presence of any one of the microbiota-asso-
ciated conditions (coeliac, diverticulitis, arthritis, IBD and
multiple sclerosis) was considered. Nominally significant
meta-data variables were added to a single permutational
multivariate analysis of variance model to identify overall
effect sizes. The cumulative effect was calculated based
on these pre-defined groups of variables.
Analysis of confounding variables
Clinical variables that have been reported to interact with
the microbiota were identified from the literature (supple-
mentary Table S1, available at Rheumatology online).
These included diet [Healthy Food Diversity (HFD) index]
[33], Barthel score [34], Godin leisure time activity score
[35], Mini-Mental State Examination scores [36], Mini
Nutritional Assessment [37] and Carlson co-morbidity
index [38]. Secondly, the meta-data identified as signifi-
cantly different between the subject groups were con-
firmed by a literature search (Table 1, supplementary
Table S2, available at Rheumatology online; P-adjusted
40.05) and were added to the analysis as potential
confounders.
Confounding factors were modelled using a general
linear mixed-effect model using the negative binomial dis-
tribution, and the sequencing depth was controlled for by
categorizing the number of reads into four quartiles and
adding this information as a random effect to the model.
Firstly, univariate general linear mixed-effect models were
generated with individual confounding factors as the pre-
dictor and the significant taxa as the response. The con-
founders identified as significant for individual taxa were
controlled for in a bivariate model. To maximize the
number of known confounders identified, a nominal
P-value was regarded as significant. In this model, the
effect of group category was evaluated after adjustment
for the individual significant confounders. Summary re-
ports were generated for both the univariate and bivariate
general linear mixed-effect models to explain the contri-
bution of the predictors.
An expanded methodology is available in the supple-
mentary material, available at Rheumatology online.
Results
Descriptive statistics of the study population
In the present study, samples and clinical information for
181 individuals were analysed. These patients were evenly
divided between those with normal BMD (n = 60), osteo-
penia (n = 61) and osteoporosis (n = 60) groups. Clinical,
physiological, biomedical and dietary measures were
investigated and significant differences between normal
BMD, osteopenia and osteoporosis participants were
detected. Differences in bone density measurements
(T-score and BMD of the anterior-posterior spine and
neck of femur) were confirmed and differences in BMI,
weight, circumference measures, vitamin D levels, and
the use of calcium and bisphosphonate supplements
were noted (Table 1, supplementary Table S2 and Figs
S1 and S2A and B, available at Rheumatology online).
Due to the recruitment by clinical referral of this high risk
cohort, there was a high rate of fractures in all groupings,
with percentages for one or more fractures being 40%
(24/60), 59% (36/61) and 42% (25/60) for normal BMD,
osteopenia and osteoporosis groups, respectively, and
percentages for two or more fractures being 7% (4/60),
23% (14/61) and 15% (9/60), respectively.
Microbiota characterization
The microbiota composition of the samples analysed was
dominated by phylum Firmicutes, with a mean abundance
of 78.9% across the whole dataset, followed in rank abun-
dance order by Bacteroidetes, accounting for 14.9%.
Other phyla accounted for 5.8%, while 0.4% were unclas-
sified (supplementary Fig. S3A, available at Rheumatology
online). The core microbiota consisted of 23 genera
that were found in at least 90% of the samples. The
top five genera with mean relative abundance in
the whole dataset were Faecalibacterium (11.7%),
Bacteroides (9.4%), Roseburia (7.9%), Blautia (7.6%)
and Coprococcus (3.2%) (supplementary Fig. S3B, avail-
able at Rheumatology online). Based on principal coord-
inate analysis on different b-diversity measures, Axes 1
and 2 explained 1117% and 813% of variance, respect-
ively (supplementary Fig. S4A and Table S3, available at
Rheumatology online). The relationship of BMD measures
with global microbiota profile was visualized using dis-
tance-based redundancy analysis, testing anterior-pos-
terior spine BMD measure with BrayCurtis distance
(supplementary Fig. S4B, available at Rheumatology
online). With regard to a-diversity, an average richness
of 308.7 ± 84.2 was observed and extrapolated richness
(chao1) was estimated at 406.8 ± 122 (Fig. 1D, supple-
mentary Fig. S4C, available at Rheumatology online) No
significant difference was observed in any of the alpha
diversity indices among the three clinical groups (Fig. 1D
and E, supplementary Fig. S4C and D, available at
Rheumatology online).
https://academic.oup.com/rheumatology 3
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Association of gut microbiota with covariates
Both sets of bone density measurements and one of the
T-scores tested explained a significant amount of micro-
biota variance (P-value 40.05), verifying the original hy-
pothesis that BMD is associated with alterations in the
microbiota (Fig. 1, supplementary Table S4, available at
Rheumatology online). We extended this beta-diversity
analysis to known microbiota-associated putative meta-
data variables to measure their effect on the microbiota
(supplementary Table S4, available at Rheumatology
online). This analysis identified 20 meta-data variables to
be associated with the global microbiota profile (Fig. 1A),
with BMI having the largest effect size individually (2.1%).
An inflammatory disease index was created indicating the
presence or absence of a disease, disorder or condition.
This index showed a significant association with the b-di-
versity (Bray-Curtis P-value 0.042, R2 = 0.009).
Among the significant variables, the combined effect-
size of the different medications explained the most vari-
ance (4.8%), followed by anthropometric measures
(3.5%). Chronic diseases explained 3.5% and BMD meas-
urement was the fourth largest contributor to effect size
(2%). Nutritional information (HFD and Mini Nutritional
Assessment), cognitive measures (Mini-Mental State
Examination) and gender explained 1.4, 1 and 0.6% of
variance, respectively (Fig. 1B). Overall, a cumulative
total range of 1517% of the variance in our dataset
was explained, which indicates that stochastic factors ex-
plain the majority of the variance in global microbiota
composition (Fig. 1C). Analysis of the Food Frequency
Questionnaire data and diet quality as measured by the
HFD index revealed no significant difference in diet
composition or HFD across the three groups. Co-inertia
analysis of the Food Frequency Questionnaire dataset
with the microbiota dataset (Fig. 2A) graphically confirmed
a significant co-variation between the two datasets, which
was independent of the defined bone health groups.
Identification of significantly differentially abundant
taxa in patients with osteopenia and osteoporosis
DESeq2 statistical analysis was used to identify genera
that were differentially abundant across the groups with
adjustment for BMI and gender (Fig. 3A and B, supple-
mentary Table S5, available at Rheumatology online). In
summary, we found that Escherichia/Shigella and
Veillonella were more abundant in subjects with osteope-
nia compared with those with osteoporosis. Actinomyces,
Eggerthella, Clostridium Cluster XlVa and Lactobacillus
were more abundant in subjects with osteoporosis com-
pared with the normal BMD group. We did not identify any
taxa significantly differentially abundant in osteopenia
compared with the normal BMD group. The relative abun-
dance of these taxa is shown in Fig. 3C.
Alterations at taxonomic levels are not associated
with confounding factors
It is well established that many confounding factors may
affect the intestinal microbiota [39]. Therefore, it is import-
ant to account for confounders potentially affecting the
significant taxa identified. We implemented an in-depth
statistical analysis to control for potential cofounders
based on a combination of previously published
approaches [39, 40]. Each significant taxon was tested
against the confounding meta-data factors as outlined in
TABLE 1 Significant characteristics of the participants in the final dataset
Meta-data Healthy (n = 60) Osteopenia (n = 61) Osteoporosis (n = 60) Significance
Gender (male/female) 13/47 7/54 11/49 NS
Age (years) 63.57 ± 5.73 64.84 ± 5.28 65.07 ± 5.58 NS
BMI 29.09 ± 4.57 27.20 ± 4.80 23.96 ± 3.31 ***
Weight (kg) 78.86 ± 13.60 70.96 ± 14.44 61.65 ± 9.44 ***
Waist circumference (cm) 95.71 ± 11.95 (13/46) 89.81 ± 12.40 (6/54) 81.81 ± 9.36 ***
Hip circumference (cm) 106.71 ± 9.83 (13/46) 103.63 ± 10.45 (6/53) 96.66 ± 7.26 ***
Waisthip ratio 0.90 ± 0.08 (13/46) 0.87 ± 0.06 (6/53) 0.85 ± 0.07 **
Mid arm circumference (cm) 30.98 ± 3.62 (12/47) 28.85 ± 3.97 26.80 ± 2.91 ***
Calf circumference (cm) 37.69 ± 3.73 (11/47) 35.76 ± 4.28 33.93 ± 2.76 ***
AP spine T-score 0.28 ± 1.02 1.16 ± 0.87 2.86 ± 0.74 ***
AP spine BMD (g/cm2) 1.22 ± 0.13 1.04 ± 0.11 0.84 ± 0.09 ***
Neck-femur T-score 0.54 ± 0.35 1.27 ± 0.53 1.95 ± 0.80 ***
Neck-femur BMD (g/cm2) 0.98 ± 0.09 0.84 ± 0.07 0.84 ± 0.68 ***
Vitamin D3 [25(OH)D3] (nmol/L) 60.49 ± 20.84 69.98 ± 25.27 75.96 ± 26.43 **
Total Vitamin D [25(OH)D)] (nmol/L) 63.68 ± 20.57 72.40 ± 25.36 79.18 ± 26.07 **
Calcium supplements (yes/no) 10/50 31/30 35/25 ***
Bisphosphonate medication (yes/no) 4/56 6/55 17/43 ***
Group-wise comparisons of the clinical variables. KruskalWallis or 2 statistic was used to determine significance. The values
represent mean ± S.D. or number of samples per group. 25(OH)D3: vitamin D3; Total Vitamin D [25(OH)D]: total vitamin D.
Significance: P-adjusted. ***40.0005; **40.005; NS: not significant. Values in brackets for circumference measures and waist-
hip ratio represents different sample size. The complete list of sample characteristics along with pairwise comparisons is
available in supplementary Table S2, available at Rheumatology online. AP: anterior-posterior.
4 https://academic.oup.com/rheumatology
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FIG. 1 Effect size of covariates significantly associated with global microbiota profiles
Significance was defined as a P-value of 0.05. (A) A total of 20 factors were identified to be nominally significantly
associated with b-diversity. The bar plot shows the variation explained by each factor individually on microbiota com-
position (weighted and unweighted UniFrac). The factors are sorted based on their mean cumulative (grouped into
predefined categories) and individual effect size from both distance measures. (B) The combined variance explained by
the predefined categories. (C) The donut plot shows the portion of combined variance explained by the nominally
significant factors on weighted and unweighted UniFrac measures, respectively. (D and E) The lack of significant dif-
ference in observed species diversity measure and Shannon index, respectively. PPIs: proton pump inhibitors; MNA: Mini
Nutritional Assessment; HFD: Healthy Food Diversity; MMSE: Mini-Mental State Examination.
https://academic.oup.com/rheumatology 5
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the Methods section. A total of 29 factors and the inflam-
matory disease index were analysed and based on the
results of the univariate models (supplementary Table
S6, available at Rheumatology online), the bivariate
models explaining the associations with each significant
genus were generated (supplementary Table S7, available
at Rheumatology online).
Significant associations with the different significantly dif-
ferentially abundant genera were explained by a range of
factors including diet, frailty variables, levels of physical ac-
tivity, medications, weight, BMI, gender and bone density
measurements, including the osteopenic and osteoporotic
groups (supplementary Table S6, available at Rheumatology
online) based on the univariate models. Based on the
bivariate models, five of the six previously identified genera
remained significantly differentially abundant after adjust-
ment for known confounding factors (supplementary Table
S7, available at Rheumatology online). The inflammatory dis-
ease index did not show any significant association with
these significant taxa in the bivariate models. Lactobacillus
abundance was not significantly associated with any of the
bone density measurements in the univariate and bivariate
models unless BMI was included in the model and therefore
was no longer considered.
Ouranalysisshows thatBMI is significantlyassociatedwith
anterior-posterior spine BMD measures but not with lowest
neck of femur BMD values (supplementary Tables S8a and
S9a, available at Rheumatology online). The removal of the
effect of BMI, medications and vitamin D levels (supplemen-
tary Tables S8be and S9be, available at Rheumatology
online) retained all but two of the results, with Clostridium
XlVa and Veillonella losing significance (supplementary
Tables S8f and S9f, available at Rheumatology online).
Discussion
This is the largest study to-date to investigate associ-
ations between the microbiota and reduced bone density
FIG. 2 Food profile is significantly associated with microbiota profile based on the CIA
(A) The CIA of the FFQ PCA and microbiota PCA, where the arrows relate the position of the samples in the FFQ dataset
in relation to the microbiota dataset. (B) The FFQ item category associated with the visualized trends. Green dots
represent fruits and vegetables, orange represents grains, cereals and bread, brown represents meats, cyan represents
fish, yellow represents dairy products, blue represents sweets, cakes and alcohol, and grey represents vitamins, minerals
and tea. The food items on the most extreme ends are labelled. (C) The microbial taxa at family level associated with
visualized trends. The taxa present at the extreme ends are labelled. CIA: co-inertia analysis; FFQ: Food Frequency
Questionnaire; PCA: principal component analysis.
6 https://academic.oup.com/rheumatology
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in a human cohort including individuals suffering from
osteopenia and osteoporosis. We have identified signifi-
cant associations between different gut microbial genera
and reduced bone density in this well-characterized
cohort. Extensive investigation by considering the poten-
tial influence of various confounders clearly established
that the taxonomic differences observed are not explained
by the confounders.
It has been observed that the microbiome field suffers
from a proliferation of small datasets that show associ-
ations of the microbiome with particular diseases or
states, without the ability to adequately control for con-
founding variables. Here we show that global alterations in
the gut microbiota are associated with BMD measures,
and these interactions explain a similar amount of vari-
ance compared with other known microbiota-associated
diseases and disorders. This confirms our hypothesis of
the association of the gut microbiota alterations with a
reduction in BMD in the elderly.
Diseases, disorders and medical conditions are asso-
ciated with smaller effect sizes compared with medica-
tions [39, 41]. In-depth analysis of confounding variables
revealed that bisphosphonate and calcium supplements
show no significant association with the global microbiota
profile. This is consistent with previous reports that
bisphosphonates are not significantly associated with
gut microbiota markers and the evidence for microbiota
alteration in association with calcium intake is weak [42].
We identified six individual gut microbial taxa that may
affect bone metabolism. This modest result contrasts
with a small cohort study that identified a large number
of alterations associated with osteoporosis and osteope-
nia patients in the microbiota at the global and genus level
[43]. The lack of replication of these global alterations in
this cohort shows the importance of adequate sample
sizes and controlling for multiple testing when investigat-
ing possible new associations.
A loss of microbiota diversity is associated with a wide
range of disease states, and microbiota diversity is widely
considered as an important indicator of health. Within this
context, the lack of significant differences in the within-
sample diversity measures is interesting. However, it has
been observed previously that despite loss of commensal
population with the elderly microbiota and noticeable dif-
ferences in microbiome composition and other host-asso-
ciated factors (e.g. inflammation, dietary patterns), there
was no significant observable difference in overall diver-
sity in ageing individuals [44] and between frail and non-
frail elderly individuals [40].
The taxa identified resonate well with the bone dens-
itymicrobiome literature. Actinomyces abundance in the
osteoporosis group here is in concordance with findings
that Actinomyces is involved in the development of
bisphosphonate-related osteonecrosis of the jaw [45],
and it has been proposed that prolonged courses of anti-
microbial therapy targeting this organism may lead to
FIG. 3 Taxa with differential abundance across the BMD groups
Plot of the log2-fold difference from the significantly differentially abundant genera in pairwise analysis between the
groups from the DESeq2 analysis when the model is adjusted for BMI and gender. Based on the log2-fold difference, (A)
shows the genera that are significantly higher in osteoporosis compared with normal BMD, (B) represents the genera that
are significantly more abundant in osteoporosis compared with osteopenia and (C) represents the relative abundance of
the significant genera in the three groups identified in DESeq2.
https://academic.oup.com/rheumatology 7
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better clinical outcomes [46]. The increase in Clostridium
XlVa in the osteoporotic group represents a means by
which the gut microbiota may influence bone state
acting through several differentiating mechanisms [47].
Clostridium XlVa induces accumulation and differentiation
of T-regulator cells, which in turn are responsible for bone
homeostasis [48]. Clostridium XlVa is an important produ-
cer of butyrate, a short chain fatty acid known to stimulate
bone formation [49]. Further functional analysis of this
group of microorganisms may provide insight into how
the gut microbiota affects BMD through modulation of
the host’s immune system and metabolism.
Vitamin D receptor polymorphisms are associated with
increased osteoporotic fracture risk [50]. The increase in
Eggerthella abundance in the osteoporotic group is of
interest, as absence of the vitamin D receptor leads to
increased Eggerthella abundance and other unfavourable
alterations in the intestinal microbiota in murine models
[51]. The current investigation also found that vitamin D
concentration is associated with a decrease in the relative
abundance of Escherichia/Shigella (supplementary Tables
S6 and S7, available at Rheumatology online), mirroring
other findings looking at vitamin D supplementation [52].
The high relative abundance of this genus in osteopenic
but not in osteoporotic patients may be partially due to the
greater use of oral vitamin D supplementation among the
patients with osteoporosis.
A number of microbes belonging to the phylum
Firmicutes are known metabolizers of isoflavone diadzin
to equol, which is an oestrogen analogue [53]. This in-
cludes species from the genus Veillonella, which we
have observed to be decreased in osteoporotic patients.
This suggests that a reduction in Veillonella would lead to
lower production of equol, which in turn leads to a lack of
inhibition of bone resorption.
An analysis of the meta-data revealed that diet and BMI
were large contributors to variance in the dataset, with
BMI being the largest single contributor, in line with nu-
merous reports linking gut microbiota with obesity [41].
Our study investigated and confirmed the effect of these
variables that can alter the microbiota as reported by pre-
vious studies. These included various medications that
have a profound effect on the microbiota profiles such
as proton pump inhibitors and the general term of poly-
pharmacy [42, 54]. Thus, the current study corroborates
previous reports which show that cumulative medication
use has the largest effect size on global microbiota pro-
files [39, 41]. However, neither these alterations nor
chronic diseases [41, 55] or anthropometric measures ex-
plained the observed microbiota alterations.
The relationships between BMI and BMD and the
microbiota is complex. Although lower BMI has been
associated with a higher fracture rate [56], a high
amount of fat mass may provide no beneficial effect on
bone health [57]. Within this study, individuals with a
higher BMI tended to have higher BMD, which is consist-
ent with the literature [58]. BMI is known to be associated
with microbiota alterations. Our analysis has considered
both of these BMI associations. Of the taxa related to
BMD, Lactobacillus and Veillonella were significantly
related (P-value <0.05) to both the obese category and
BMD, while Clostridium XlVa showed trends of associ-
ations with the obese category (P-value <0.1). However,
the Lactobacillus correlation was not significant without
adjustment for BMI and so was considered a false posi-
tive. Further analysis showed that with removal of variance
associated with BMI and medications from the BMD
measures results in Veillonella and Clostridium XlVa
losing significance. Other results were unaffected, show-
ing that the associations are independent of BMI.
Therefore, the association of Clostridium XlVa and
Veillonella with BMD should be interpreted with caution.
This is the first investigation of the intestinal microbiota
in a large well-characterized human adult cohort with re-
spect to BMD, with one previous study having a limited
sample size [43]. Nevertheless, the current study has cer-
tain limitations. Due to the recruitment of individuals
through consultant referral, the normal BMD cohort are
not truly representative of the general population, as high-
lighted by the high fracture rate in this group. However, a
history of fractures was not associated with a detectable
alteration in the microbiota, and controlling for this vari-
able confirmed the BMD results but did not improve the
analysis. Due to the incomplete information of the standa-
lone vitamin supplements, we included serum vitamin D
levels to use directly measured concentrations to account
for vitamin D. The number of variables that can be tested
in the identification of confounding factors through statis-
tical analyses is limited by the sample size. However, this
analysis was not dependent on the statistical identification
of confounding variables, with the majority of the variables
being identified from the literature before the commence-
ment of the analysis, and with all additional variables
being supported by the literature. The reported study is
also observational and the association with BMD does not
imply direct causation. However, the literature supports
the notation that these taxa may have functional links to
bone health and this microbial contribution to bone health
may represent a modifiable environmental factor in the
prevention and treatment of osteoporosis. Despite the
limitations discussed, changes in gut bacterial compos-
ition with respect to bone health suggest that further ex-
ploration and mechanistic studies are warranted.
In conclusion, we identified taxa-specific differences in
the gut microbiota profiles associated with normal BMD,
osteopenic and osteoporotic subjects. These genera
could be potential biomarkers and therapeutic targets in
high risk cohorts. These differences support the concept
that specific genera within the gut exert influence on bone
metabolism in the host, subsequently affecting bone
health in adulthood.
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